Search

everythinglearnresearchcommunity

for

Search:↓

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

Medications improve quality of life for men with lower urinary tract symptoms.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Men with lower education levels are more likely to have erectile dysfunction if they have coronary artery disease.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

ELF5 is essential for skin cell growth and maintenance.

Dutasteride safely treats hair loss without harming sexual function.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Elf5 is important for skin stem cell growth and could help treat skin and hair problems.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Finasteride improves heart function and balance in aging and obese male rats by reducing oxidative stress.

Finasteride may cause weak ejaculation and reduced semen volume.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.